share_log
Reuters ·  Mar 19 12:09
Olema Pharmaceuticals, Inc. : Oppenheimer Cuts Target Price to $25 From $30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 391

Recommended

Write a comment